Revisiting the cardiometabolic relevance of serum amylase

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Nakajima, Kei ^a,c   Muneyuki, Toshitaka ^b   Munakata, Hiromi ^c   Kakei, Masafumi ^b  

^a JOSAI UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Social Insurance Omiya General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054118870     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-419     Document Type: Article

References (23)

1. The role of gut hormones in glucose homeostasis. Drucker DJ, J Clin Invest 2007 117 24 32 10.1172/JCI30076 17200703 (Pubitemid 46048446)
2. The islet-acinar axis of the pancreas: more than just insulin. Barreto SG, Carati CJ, Toouli J, Saccone GT, Am J Physiol Gastrointest Liver Physiol 2010 299 10 22 10.1152/ajpgi.00077.2010 20395539
3. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Frier BM, Faber OK, Binder C, Elliot HL, Diabetologia 1978 14 301 304 10.1007/BF01223020 348540 (Pubitemid 8321890)
4. Exocrine pancreatic function in diabetes mellitus. Dandona P, Freedman DB, Foo Y, Perkins J, Katrak A, Mikhailidis DP, Rosalki SB, Beckett AG, J Clin Pathol 1984 37 302 306 10.1136/jcp.37.3.302 6699193 (Pubitemid 14192881)
5. Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus. Swislocki A, Noth R, Hallstone A, Kyger E, Triadafilopoulos G, Horm Metab Res 2005 37 326 330 10.1055/s-2005-861478 15971157 (Pubitemid 40896217)
6. Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus. Aughsteen AA, Abu-Umair MS, Mahmoud SA, Saudi Med J 2005 26 73 77 15756357 (Pubitemid 40372504)
7. Low serum amylase in association with metabolic syndrome and diabetes: A community-based study. Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H, Cardiovasc Diabetol 2011 10 34 10.1186/1475-2840-10-34 21496338
8. The potentiating influences of insulin on pancreozymin-induced hyperpolarization and amylase release in the pancreatic acinar cell. Kanno T, Saito A, J Physiol 1976 261 505 521 978585
9. Insulin resistance is accompanied by impairment of amylase-gene expression in the exocrine pancreas of the obese Zucker rat. Trimble ER, Bruzzone R, Belin D, Biochem J 1986 237 807 812 2432875 (Pubitemid 16003784)
10. Hyperglycaemia but not hyperlipidaemia decreases serum amylase and increases neutrophils in the exocrine pancreas of cats. Zini E, Osto M, Moretti S, Franchini M, Kook PH, Lutz H, Guscetti F, Perren A, Hoelzle LE, Ackermann M, Lutz TA, Reusch CE, Res Vet Sci 2010 89 20 26 10.1016/j.rvsc.2010.01.006 20132955
11. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA, BMJ 2011 342 636 10.1136/bmj.d636 21343206
12. Low serum amylase levels in drinking alcoholics. Maruyama K, Takahashi H, Okuyama K, Yokoyama A, Nakamura Y, Kobayashi Y, Ishii H, Alcohol Clin Exp Res 2003 27 16S 21S 10.1097/01.ALC.0000078827.46112.76 12960501 (Pubitemid 36999194)
13. Irreversible exocrine pancreatic insufficiency in alcoholic rats without chronic pancreatitis after alcohol withdrawal. Li J, Zhou C, Wang R, Liu R, Huang Z, Tang C, Alcohol Clin Exp Res 2010 4 1843 1848
14. Alcohol consumption and type 2 diabetes Meta-analysis of epidemiological studies indicates a U-shaped relationship. Carlsson S, Hammar N, Grill V, Diabetologia 2005 48 1051 1054 10.1007/s00125-005-1768-5 15864527 (Pubitemid 40909637)
15. Report of the committee on the classification and diagnositic criteria of diabetes mellitus: The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K, J Diabetes Investigation 2010 1 212 228
16. Is obesity a major cause of chronic kidney disease? Hall JE, Henegar JR, Dwyer TM, Liu J, Da Silva AA, Kuo JJ, Tallam L, Adv Ren Replace Ther 2004 11 41 54 10.1053/j.arrt.2003.10.007 14730537 (Pubitemid 38174673)
17. Obesity and renal hemodynamics. Bosma RJ, Krikken JA, Homan van der Heide JJ, de Jong PE, Navis GJ, Contrib Nephrol 2006 151 184 202 16929142 (Pubitemid 44298232)
18. Early detection and treatment of diabetic nephropathy. Woredekal Y, Pediatr Endocrinol Rev 2008 Suppl 4 999 1004
19. Clinical significance of amylase isoenzyme determination. Skrha J, Stpán J, ActaUniv Carol Med Monogr 1987 120 1 81
20. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Layer P, Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP, Mayo Clin Proc 1986 61 442 447 2423813 (Pubitemid 16100857)
21. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control. Barrett ML, Udani JK, Nutr J 2011 10 24 10.1186/1475-2891-10-24 21414227
22. Expression of alpha-amylase isozymes in rat tissues. Hokari S, Miura K, Koyama I, Kobayashi M, Matsunaga T, Iino N, Komoda T, Comp Biochem Physiol B Biochem Mol Biol 2003 135 63 9 12781974 (Pubitemid 36627731)
23. Expression of pancreatic digestive enzymes in normal and pathologic epithelial cells of the human gastrointestinal system. Terada T, Kitamura Y, Ashida K, Matsunaga Y, Kato M, Harada K, Morita T, Ohta T, Nakanuma Y, Virchows Arch 1997 431 195 203 10.1007/s004280050088 9334841 (Pubitemid 27440364)